Establishing the Superiority of Topical Diltiazem over Glyceryl Trinitrate in the Treatment of Chron...

Vivek Tomar, Ashish Saxena

  Open Access OPEN ACCESS  Peer Reviewed PEER-REVIEWED

Establishing the Superiority of Topical Diltiazem over Glyceryl Trinitrate in the Treatment of Chronic Anal Fissure: a Prospective Analytical Study

Vivek Tomar1, Ashish Saxena2,

1Department of General Surgery, Civil Hospital, Moga, India

2Department of General Surgery, Hindu Rao Hospital, New Delhi, India

Abstract

Introduction: Anal fissure is a common ailment of young age group, affecting males and females alike. Traditionally surgery has been the 1st line of treatment but recently the topical agents such as Glyceryl Trinitrate and Diltiazem are replacing the surgical treatment as preferred modality. Objective: The present study was conducted to compare the topical GTN and DTZ in terms of effectiveness, side effects and patient satisfaction. Material and methods: The study was conducted on 50 patients who were divided into 2 groups- Group I and Group II. Group I patients were treated with topical 2% DTZ while Group II patients were put on topical 0.2% GTN. Cases were kept in follow up for 6 weeks and data thus gathered was analyzed. Results: No significant difference was noted in both groups in term of relief in pain, bleeding and fissure healing. However group II patients reported a higher incidence of headache associated with Topical GTN usage, when compared with the Group II patients (p <0.05). Conclusion: Topical Diltiazem is preferred to topical Glyceryl trinitrate as it is better tolerated with a fewer side effects Hence 2% DTZ should be considered as 1st line of therapy for the treatment of chronic anal fissure.

Cite this article:

  • Tomar, Vivek, and Ashish Saxena. "Establishing the Superiority of Topical Diltiazem over Glyceryl Trinitrate in the Treatment of Chronic Anal Fissure: a Prospective Analytical Study." Global Journal of Surgery 2.3 (2014): 37-41.
  • Tomar, V. , & Saxena, A. (2014). Establishing the Superiority of Topical Diltiazem over Glyceryl Trinitrate in the Treatment of Chronic Anal Fissure: a Prospective Analytical Study. Global Journal of Surgery, 2(3), 37-41.
  • Tomar, Vivek, and Ashish Saxena. "Establishing the Superiority of Topical Diltiazem over Glyceryl Trinitrate in the Treatment of Chronic Anal Fissure: a Prospective Analytical Study." Global Journal of Surgery 2, no. 3 (2014): 37-41.

Import into BibTeX Import into EndNote Import into RefMan Import into RefWorks

1. Introduction

An anal fissure is nothing but a tear in the vertical axis of squamous lining of the anal canal between the anal verge and dentate line. [1] It is a painful condition characterized by pain on defecation, bleeding per anum and spasm of anal sphincter. [2, 3] Anal fissure is a very common problem across the world, particularly affecting the young and otherwise healthy adults with equal incidence across both sexes. [1] Estimate of the incident of this condition is difficult as many patients with acute fissures do not seek medical advice due to embarrassing nature of the problem. It causes considerable morbidity and adversely affects the quality of life, and therefore appropriate treatment is mandatory.

Majority of anal fissures are probably acute and relatively short lived, resolving, spontaneously or with dietary modification. Fissures failing to heal within 6 weeks despite straight for dietary measures are designated as chronic. [4] Although a proportion (10-30%) of fissures will eventually resolve with conservative measures, most require intervention in order to heal. [5] Traditionally surgical treatments such as manual anal dilatation and an internal sphincterotomy have been used for this ailment. [6] These methods work by causing a fall in anal canal pressure and allowing fissure healing. But due to the possibility of fecal incontinence after surgical treatment [7], alternative treatment in the form of pharmacological agents is worth trying. These agents are less invasive and the effects of treatment are reversible.

Various pharmacological agents have been used to treat fissure so far. Out of these topical hydrocortisone and local anesthetics are found to confer no added benefit over dietary bran. [8] Topical steroids are thought to precipitate extensive anal herpes and therefore abandoned. The discovery of agents, that produce reversible relaxation of anal sphincters, has brought a paradigm shift in the medical management of anal fissure. Out of such agents, Glycryl Trinitrate (GTN) and Diltiazem (DTZ) are the forerunners. [9] These drugs have become the first line treatment for anal fissure, reserving the surgery for failures or recurrences. These agents heal the fissure so effectively that the pharmacological treatment of anal fissure has been termed as ‘Chemical sphincterotomy’ [10].

Topical Glyceryltrinirate (GTN) acts by releasing nitric oxide, a neuro-transmitter which mediates the relaxation of internal anal sphincter. This relaxation of sphincter facilitates the optimal healing of fissure. [11] Approximately two-third of patients using GTN ointment or patch develop headache as a side effect, which may be severe enough to warrant cessation of treatment [12].

Topical Diltiazem (DTZ) on the other hand is a calcium channel blocker which works by preventing the influx of calcium into the smooth muscle cell, decreasing intracellular calcium concentration, thus hindering the smooth muscle contraction. In addition to relax the smooth muscles of internal sphincter, they also dilate the blood vessels of the anoderm, leading to an increased blood flow resulting in a faster recovery [13].

Keeping these facts in mind, the present study was conducted to compare the effectiveness and side effects of both the drugs and to determine the topical agent of choice for the treatment of chronic anal fissure.

2. Aims and Objectives

1. To compare the results of topical Diltiazem (DTZ) and Glyceryltrinitrate (GTN) in the treatment of chronic anal fissure.

2. To determine the topical agent of choice for the treatment of anal fissure that, imparts good healing and has lesser side effects and recurrence rate.

3. Materials and Methods

This was a prospective comparative study conducted in a government run tertiary care hospital, catering the suburban and rural population. The study was carried out on 50 patients presenting with chronic anal fissure between May, 2011 and June, 2012. Informed written consent was taken from all the patients. Clearance from the local ethical committee was obtained for the study.

Inclusion criteria for the study was as follows

•  Presence of chronic anal fissure for more than 8 weeks that had failed to resolve with simple measures such as laxatives & high fiber diet.

•  Examination revealing features of chronicity such as induration at the edges, external skin tag, and exposure of the horizontal fibers of the internal anal sphincter on the floor.

Following patients were excluded from the study

•  Those having anal fissure due to other diseases such as inflammatory bowel disease, tuberculosis, malignancy, or STD.

•  Those who had taken prior course of topical agents.

•  Those who had undergone surgery for anal fissure in past.

•  Those having associated hemorrhoids or fistula.

•  Pregnant or lactating women.

•  Patients with significant cardiovascular conditions.

The subjects were treated as outpatients. Clinical examination, including digital rectal & proctoscopic examination, was performed on all the subjects. Sigmoidoscopy & colonoscopy were performed as & when necessary.

Subjects were divided into two groups, Group I & Group II. 25 patients were allotted to each group after randomized by sequential order. Subjects in Group I were treated with 2% Diltiazem ointment while Group II subjects were instructed to use 0.2% Glyceryl Trinitrate (GTN) ointment twice daily for 6 consecutive weeks.

Both groups were advised to apply their respective ointment 1.5 to 2 cm deep into the anal canal. The application was to be done either with clean index finger or by taking the gel on a clean piece of gauge/cotton and gently pushing it into the anus. The subjects were instructed to apply ointment before and after every defecation. Application of ointment at bedtime was compulsory.

The subjects were assessed on 2nd, 4th and 6th weekend during the course of the treatment & then onwards bimonthly up to six months. At each visit, fissure healing, pain relief, any side effects & recurrence were recorded. The treatment protocol was considered violated if a patient didn't comply with the treatment as advised. Symptomatic relief in terms of pain and bleeding was assessed on follow up. Healing of the fissure was assessed visually and results were compiled as Very good (complete), Good (partial) and Poor (no healing). The disease was termed recurrent if the fissure reappeared at the same site one month after 6 weeks course of topical application.

Data was collected and was analyzed statistically. The P values were calculated using chi-square test and were considered significant below a value of 0.05.

4. Results

A total number of 50 cases of chronic anal fissure were included in this prospective comparative study. The cases were divided into two groups, Group I and Group II, comprising of 25 cases each. Group I was put on 2% DTZ ointment, while Group II on 0.2% GTN ointment.

A detailed history and examination of each patient was recorded on admission and again when the patients came for follow up. Then the results were evaluated on each visit in terms of symptomatic relief, healing and any recurrences and complications on further follow up. Results thus obtained are described in tabulated and graphical forms.

Mean age in two groups was fairly similar. DTZ group had a mean age of 40.32 years while GTN group had mean age of 38.52 years. Both groups showed male predominance. 60% of patients in DTZ group and 52% in GTN group were males.

Main presenting complaints were pain while defecation and bleeding per anum. Other minor complaints were Mucoid discharge per anum, anal tag, constipation and Pruritus. Almost all cases complained of pain during defecation. Only 8% patients in DTZ group and 4% in GTN group did not give history of any pain during defecation. On the other hand, only 28% of patients in DTZ group and 20% in GTN group reported having pain after defecation. One patient complained of continuous pain, both during and after defecation.

Most of the cases (80% in each group) presented with compain of bleeding while passing stools. While only 3 cases out of 25 in DTZ group and none in GTN group had complaint of bleeding after stool passage. None of the patients reported of having episodes of bleeding between two motions.

12% of cases in DTZ group and 8% in GTN group had complaint of mucoid discharge per anum. 32% of patients in DTZ group and 48% of case in GTN group complained of presence of an anal tag. Constipation was reported by 60% of patients in DTZ group and 56% of patients in GTN group. 20% of patients in DTZ group and 24% in GTN group were suffering from pruritus.

Upon local examination, maximum number of cases (80% in each group) were having fissure in a posterior position upon the anal verge. Anterior fissure was reported by 28% of cases in DTZ group and 32% in GTN group. None of the patients had a lateral fissure. 92% of cases in DTZ group and 84% of cases in GTN group had a single fissure, while the remaining patients had multiple fissures. 68% of patients in DTZ group and 88% in GTN group had sentinel piles on examination.

2 weeks after commencement of treatment, 56.52% of cases in DTZ group and 59.09% in GTN group had no complaint of pain. After 4 weeks and 6 weeks however, 86.96% and 91.31% of cases in DTZ group and 77.28% and 81.82% of cases in GTN group respectively were relieved of pain (Graph 1).

The complaint of bleeding per anum was resolved in 86.95% of patients in DTZ group and 77.27% of cases in GTN group after 2 weeks of treatment. After 4 weeks of treatment, 95.66% cases in DTZ group and 81.82% cases in GTN group were relieved of bleeding. After 6 weeks, 95.66% cases in DTZ group and 90.91% cases in GTN group were not bleeding at all (Graph 2).

Healing of fissure was noted in 4.34% of patients in DTZ group and 4.54% of cases in GTN group after 2 weeks of treatment. After 4 weeks, 56.52% of fissures in DTZ group and 54.54% of fissures in GTN group were found to be healed. At the end of 6th week, complete fissure healing was seen in 78.26% of cases in DTZ group and 68.18% of cases in GTN group (P< 0.05) (Graph 3).

Main complications observed during the study period were headache, perianal itching and recurrence. 8.69% of cases from DTZ group developed headache during the course of treatment, as compared with 50% of cases in GTN group (p< 0.05). Perianal itching was reported by 4.34% of cases in DTZ group and 9.09% of cases in GTN group. Recurrence was seen in 8.69% of cases in DTZ group, as compared to 18.18% in GTN group (Graph 4).

Overall, slightly better results in terms of patient satisfaction were shown by DTZ group (Graph 5).

•  Ages of the patients were fairly similar in both groups.

•  In both groups, there was a slight male predominance.

•  Pain was the main presenting symptom especially during defecation followed by the bleeding per rectum.

•  Majority of the cases had constipation.

•  Posterior midline was the most common location and majority of fissures were associated with sentinel piles.

•  3 cases from GTN group & 2 cases from DTZ group failed to complete the study due to headaches and cooperation problems. Those subjects were not considered in the final statistical analysis.

•  Main complaints (pain and bleeding) were resolved after 6 weeks of treatment in majority of patients (Graph 1 & 2), with no significant difference between two groups (p >0.05).

•  No significant difference in both groups was seen in terms of fissure healing after 6 weeks of treatment. (Graph 3) (p >0.05).

•  Headache was seen in almost half of the cases in GTN group as compared to very few cases in DTZ group (Graph 4), and the difference was statistically very significant (p <0.05). One patient in DTZ group required analgesic, while 7 cases in GTN group requested for pain killers.

•  No significant difference was observed in perianal itching after topical application of ointment and recurrence rate was also almost similar, with slightly greater incidence observed in GTN group (P >0.05) (Graph 4).

•  Results were found to be more promising with DTZ group (Graph 5).

5. Discussion

Anal fissure is a slit in the lining of the distal anal canal [14] & is the most common cause of severe anal pain. [15] Posterior midline is the commonest site, but anterior midline fissures are not infrequent, especially in females. [16, 17] Constipation & passage of hard stool have been known to be the initiating factors of fissure. In females, it is usually triggered during pregnancy and following childbirth. [15] They can be associated with inflammatory bowel disease & tuberculosis.

There is no agreement in the literature on the criteria to define chronic anal fissure, so we used the time of duration of symptoms and the signs of chronicity seen on exploration. Most authors arbitrarily use a 6 week time of evolution as a selection criterion. [4] Following Nelson’s directives in his review of Cochrane, [19] we have used both evolution and morphological data to select chronic anal fissure. We considered the ailment as chronic when there was a history of pain of more than 6 weeks duration or pain of less duration, but with similar episodes in the past, or with signs of chronicity.

The exposed internal sphincter muscle underneath the fissure goes into spasm resulting in severe pain. Besides, the spasm pulls the edges of the fissure apart, which impairs healing of the wound. The typical symptoms of anal fissure are anal pain during defecation associated with the passage of bright red blood per rectum. The pain may be so severe that patients may postpone defecation for days together until it becomes inevitable. This leads to hardening of the stools, which further worsens the condition. The fissures can be either acute or chronic. Acute fissure is of short duration (less than a month) and has fresh mucosal edges. They usually heal spontaneously or with simple measures like high fibre diet, adequate water intake, and warm sitz baths. Chronic fissures generally have indurated edges. External skin tag (sentinel pile) is commonly observed. Horizontal fibers of the internal sphincter are usually exposed on the floor of the well developed fissure, which leads to spasm due to irritation [14, 15].

Acute anal fissures tend to cure with simple conservative measures, whereas chronic fissures usually need other forms of definitive therapy, either medical or surgical. [18] Various treatment modalities have been described which may be grouped into non-operative and operative measures.

Non-operative methods include Injection of Botulinum toxin, oral nifedipine, topical application of glyceril trinitrate (GTN) and topical diltiazem ointment. Botulinum toxin is effective in treating fissures that have failed to heal with topical agents. Botulinum toxin can also be combined with surgical modalities. Lindsey et al. [20] showed that, following injection of 25 U of Botox into the internal sphincter combined with fissurectomy in 30 patients (19 of whom had failed both GTN and botulinum toxin injection), 28 (93%) had healed after a median of 16.4 weeks' follow-up. Dysport is an alternative tolerable commercial formulation of botulinum toxin to Botox; however, the change in dose needs attention as, in one study by Brisinda et al, [21] patients with fissures were randomised to receive 50 U of Botox formulation or 150 U of Dysport.

Topical GTN has been the most extensively used non-surgical treatment for chronic anal fissure. [22] It is a potent nitric oxide donor [23] & it has been believed that nitric oxide is a neurotransmitter mediating the relaxation of the internal sphincter. [14] GTN ointment or patch applied to the anal verge results in the healing of approximately two-thirds of chronic anal fissures. [16, 24, 25] But headache and dizziness are its main drawbacks.16 The headache is dose-related and was found to be occurring in around 50% of patients in a study by Bailey et al. [26]. Danish et al have shown that GTN-associated headache sometimes became so severe and intractable that the treatment has to be abandoned. [12] Besides, tolerance to nitrates is a well documented fact. [16] Another drawback associated with GTN therapy is high recurrence rate [22, 27].

Isosorbide dinitrate (ISDN) is an alternative nitric oxide donor that has been used successfully in the treatment of anal fissures. The problems encountered are similar to those with GTN but long-term effectiveness has been questioned [28, 29].

Nifedipine and Diltiazem are calcium channel blockers which act by blocking slow L-type calcium channels in smooth muscle causing relaxation. [14] Topical Diltiazem has been reported to result in the healing of chronic anal fissure in 60% to 75% of cases. [1, 13, 16] In a study, Carapeti et al reported fissure healing in 67% of patients treated with GTN [24], while headache was observed in 72% of cases. In another study, Knight et al from UK observed 75% of their cases had fissure healed with topical Diltiazem. Only 1 of 71 cases had headache [13].

Topical Diltiazem, a non-dihydropyridine calcium-channel blocker also has been tried successfully in the treatment of chronic anal fissure that have failed to respond to GTN. [1, 17] Diltiazem ointment has been known to cause less headache & a fewer side effects than GTN ointment without a significant difference in healing rates between the two agents. [13, 30] Also, recurrence rate has been known to be lower with topical Diltiazem [1, 30, 31, 32]

Fissures which refuse to heal or recur with this conservative topical regimen should be treated with internal sphincterotomy, which is the currently accepted gold standard treatment [33].

6. Summary & Conclusion

Both Diltiazem ointment (2%) and Glyceryl trinitrate ointment (0.2%) are quite effective in the treatment of chronic anal fissure. However, topical Diltiazem is preferred to topical Glyceryl trinitrate as it is better tolerated with a fewer side effects. Therefore, 2% diltiazem should be considered the first line therapy for the treatment of chronic anal fissure. Surgical intervention should be reserved for the failure or recurrence after the trial of chemical sphincterotomy.

References

[1]  Bhardwaj R, Parker MC. Modern perspectives in the treatment of chronic anal fissures. Ann R Coll Surg Engl 2007; 89 (5): 472-8.
In article      CrossRefPubMed
 
[2]  Hussain SM, Aziz I, Arif M. Anal fissure. Professional Med J 2005; 12: 376-8.
In article      
 
[3]  Wehrli H. Etiology, pathogenesis and classification of anal fissure. Swiss Surg 1996; (1): 14-7.
In article      PubMed
 
[4]  Lindsey I, Jones OM, Cunningham C, Mortensen NJ. Chronic Anal Fissure. Br J Surg 2004; 91: 270-9.
In article      CrossRefPubMed
 
[5]  Fox A, Tietze PH, Ramakrishnan K. Anorectal conditions: anal fissure and anorectal fistula. FP Essent. 2014 Apr; 419: 20-7.
In article      PubMed
 
[6]  Ram E, Alper D, Stein GY, and et al. Internal anal sphincter function following lateral internal sphincterotomy for anal fissure: a long-term manometric study. Ann Surg 2005; 242: 208-11.
In article      CrossRefPubMed
 
[7]  Lewis TH, Corman ML, Prager ED, Robertson WG. Long-term results of open and closed sphincterotomy for anal fissure. Dis Colon Rectum 1988; 3: 368-71.
In article      CrossRef
 
[8]  Jensen SL. Treatment of first episodes of acute anal fissure: prospective randomised study of lignocaine ointment versus hydrocortisone ointment or warm sitz baths plus bran. BMJ. 1986; 292: 1167-9.
In article      CrossRefPubMed
 
[9]  Jawaid M, Masood Z, Salim M. Topical diltiazem hydrochloride and glyceryl trinitrate in the treatment of chronic anal fissure. J Coll Physicians Surg Pak 2009; 19: 614-7.
In article      PubMed
 
[10]  Hashmat A, Ishfaq T. Chemical versus surgical sphincterotomy for chronic fissure in ano. J Coll Physicians Surg Pak. 2007 Jan; 17 (1): 44-7.
In article      PubMed
 
[11]  Ward DI, Miller BJ, Schahe PJ, and et al. The use of glyceryl trinitrate in the treatment of acute and chronic anal fissure. Aust NZ J Surg 2000; 70: 19-21.
In article      CrossRef
 
[12]  Danish KF, Chaudhry AR, Khan SS. Intractable headache as a side effect of topical nitroglycerine ointment. Rawal Med J; 2008; 33: 15-7.
In article      
 
[13]  Knight JS, Birks M, Farouk R. Topical diltiazem ointment in the treatment of chronic anal fissure. Br J Surg. 2001; 88: 553-6.
In article      CrossRefPubMed
 
[14]  Leong A P K. Pharmacological Treatment of Anal Fissure- A Future Role in Primary Care. Singapore Med J 2003; 44(3): 136-7.
In article      PubMed
 
[15]  Pravid J Gupta. Treatment of fissure in ano- revisited. Afr Health Sci 2004 April; 4 (1): 58-62.
In article      
 
[16]  Carapeti EA, Kamm MA, Phillips RKS. Topical diltiazem and bethanecol decrease anal sphincter pressure and heal anal fissures without side effects. Dis Colon Rectum 2000; 43:1359-62.
In article      CrossRefPubMed
 
[17]  Jonas M, Speake W, Scholefield JH. Dilitiazem heals glyceryl trinitrate - resistant chronic anal fissures: A prospective study. Dis Colon Rectum 2002; 45: 1091-5.
In article      CrossRefPubMed
 
[18]  Brugman T, Bruyninx L, Jacquet NJ. Fissure-in-ano, to divide or not to divide? Acta Chir Belg. 1999; 99: 215-20.
In article      PubMed
 
[19]  Nelson R. Non surgical therapy for anal fissure. Cochrane Database Syst Rev. 2006; CD003431. Review.
In article      
 
[20]  Lindsey I, Cunningham C, Jones OM, and et al. Fissurectomy - botulinum toxin: a novel sphincter-sparing procedure for medically resistant chronic anal fissure. Dis Colon Rectum. 2004; 47: 1947-52.
In article      CrossRefPubMed
 
[21]  Brisinda G, Albanese A, Cadeddu F, and et al. Botulinum neurotoxin to treat chronic anal fissure: results of a randomized ‘Botox vs. Dysport’ controlled trial. Aliment Pharmacol Ther. 2004; 19: 695-701.
In article      CrossRefPubMed
 
[22]  Golfam F, Golfam P, Khalaj A, and et al. The Effect of Topical Nifedipine in Treatment of Chronic Anal Fissure. Acta Medica Iranica 2010; 48 (5): 295-9.
In article      PubMed
 
[23]  Ward DI, Miller BJ, Schahe PJ, and et al. Cut or paste? .The use of glyceryl trinitrate in the treatment of acute and chronic anal fissure. Aust NZ J Surg 2000; 70: 19-21.
In article      CrossRef
 
[24]  Carapeti EA, Kamm MA, Mc Donald PJ, and et al. Randomised controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate. Gut 1999; 44: 727-30.
In article      CrossRefPubMed
 
[25]  Zuberi BF, Rajput MR, Abro H, and et al. A randomised trial of glyceryl trinitrate ointment and nitroglycerin patch in healing of anal fissures. Int J Colorectal Dis 2000; 15: 243-5.
In article      CrossRefPubMed
 
[26]  Bailey HR, Beck DE, Billingham RP, and et al. A study to determine the nitroglycerin ointment dose and dosing interval that best promote the healing of chronic anal fissures. Dis Colon Rectum 2002 Sep; 45 (9): 1192-9.
In article      CrossRefPubMed
 
[27]  Kennedy ML, Sowter S, Nguyen H, and et al. Glyceryl trinitrate ointment for the treatment of chronic anal fissure: results of a placebo-controlled trial and long term follow-up. Dis Colon Rectum 1999; 42 (8): 1000-6.
In article      CrossRefPubMed
 
[28]  Lysy J, Israelit-Yatzkan Y, Sestiere-Ittah M, and et al. Treatment of chronic anal fissure with isosorbide dinitrate: long-term results and dose determination. Dis Colon Rectum. 1998; 41: 1406-10.
In article      CrossRefPubMed
 
[29]  Werre AJ, Palamba HW, Bilgen EJ, and et al. Isosorbide dinitrate in the treatment of anal fissure: a randomised, prospective, double blind, placebo-controlled trial. Eur J Surg. 2001; 167: 382-5.
In article      CrossRefPubMed
 
[30]  Kocher HM, Steward M, Leather AJ, and et al. Randomised clinical trial assessing the side-effects on glyceryl trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure. Br J Surg 2002; 89: 413-7.
In article      CrossRefPubMed
 
[31]  DasGupta R, Franklin I, Pitt J, and et al. Successful treatment of chronic anal fissure with diltiazem gel. Colorect Dis. 2002; 4: 20-2.
In article      CrossRef
 
[32]  Bielecki K, Kolodziejczak M. A prospective randomized trial of diltiazem and glyceryltrinitrate ointment in the treatment of chronic anal fissure. Colorect Dis. 2003; 5: 256-7.
In article      CrossRef
 
[33]  de Rosa M, Cestaro G, Vitiello C and et al. Conservative versus surgical treatment for chronic anal idiopathic fissure: a prospective randomized trial. Updates Surg. 2013 Sep; 65 (3): 197-200.
In article      CrossRefPubMed
 
  • CiteULikeCiteULike
  • MendeleyMendeley
  • StumbleUponStumbleUpon
  • Add to DeliciousDelicious
  • FacebookFacebook
  • TwitterTwitter
  • LinkedInLinkedIn